FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Greenberg Robert J. 		2. Issuer Name and Ticker or Trading Symbol

SECOND SIGHT MEDICAL PRODUCTS INC [ EYES ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Chairman of Board
(Last)          (First)          (Middle)

12744 SAN FERNANDO ROAD, SUITE 400 		3. Date of Earliest Transaction (MM/DD/YYYY)

6/5/2017
(Street)

SYLMAR, CA 91342
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   5/31/2017   5/31/2017   A    13090   A $0.978   186001   (1) D    
Common Stock   6/5/2017   6/5/2017   A    13090   D $1.13   172911   (1) D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy)   $1.97                    1/3/2018   (2) 1/3/2027   Common Stock   256410     256410   D    
Non-Qualified Stock Option (right to buy)   $4.1                    1/21/2017   (2) 1/21/2026   Common Stock   57563     57563   D    
Non-Qualified Stock Option (right to buy)   $5                    2/1/2009   (3) 2/1/2018   Common Stock   23750     23750   D    
Non-Qualified Stock Option (right to buy)   $5                    11/1/2009   (3) 11/1/2018   Common Stock   150000     150000   D    
Non-Qualified Stock Option (right to buy)   $5                    2/1/2010   (3) 2/1/2019   Common Stock   33750     33750   D    
Non-Qualified Stock Option (right to buy)   $5                    2/1/2011   (3) 2/1/2020   Common Stock   103750     103750   D    
Non-Qualified Stock Option (right to buy)   $5                    3/1/2012   (3) 3/1/2021   Common Stock   41563     41563   D    
Non-Qualified Stock Option (right to buy)   $5                    3/1/2013   (3) 3/1/2022   Common Stock   38750     38750   D    
Non-Qualified Stock Option (right to buy)   $5                    4/1/2015   (3) 4/1/2024   Common Stock   46875     46875   D    
Non-Qualified Stock Option (right to buy)   $9                    9/26/2015   (3) 9/26/2024   Common Stock   414659     414659   D    
Non-Qualified Stock Option (right to buy)   $13.09                    3/25/2016   (3) 3/25/2025   Common Stock   31250     31250   D    

Explanation of Responses:
(1)  13,090 shares, acquired as part of scheduled ESPP purchases, were sold on 6/5/2017.
(2)  Options vest over a four year term of which one-fourth vests on the Date Exercisable, with the remaining options vesting quarterly over three years thereafter.
(3)  Options vest in 4 yearly increments starting with the Date Exercisable

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Greenberg Robert J.
12744 SAN FERNANDO ROAD
SUITE 400
SYLMAR, CA 91342 		X
Chairman of Board

Signatures
/s/ Robert J Greenberg 6/7/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Second Sight Medical Pro... (NASDAQ:EYES)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Second Sight Medical Pro... Charts.
Second Sight Medical Pro... (NASDAQ:EYES)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Second Sight Medical Pro... Charts.